← All companies

IVBX

Innovent Biologics, Inc.

IVBXF EDGAR ↗

$10.68

-1.46 -12.06%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$9.10 – $15.12

Recent SEC filings

2 most recent

Other filings

F-6EF Aug 8, 2025 F-6EF FORM F-6EF Apr 17, 2019